Cargando…
Adverse effects of immune checkpoint inhibitor therapies on right ventricular function and pulmonary arterial dilatation
Immunologic risk factors contribute to endothelial dysfunction and development of pulmonary vascular disease. Immune checkpoint inhibitors, used as immunotherapies for malignancies, have a wide range of reported immune-related adverse events. We retrospectively describe the impact of immune checkpoi...
Autores principales: | Mylvaganam, Ruben, Avery, Ryan, Goldberg, Isaac, Makowski, Courtney, Kalhan, Ravi, Villaflor, Victoria, Cuttica, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878999/ https://www.ncbi.nlm.nih.gov/pubmed/33623668 http://dx.doi.org/10.1177/2045894021992236 |
Ejemplares similares
-
Differences in referral to a chronic thromboembolic pulmonary hypertension center following acute pulmonary embolism: a locoregional experience
por: Mylvaganam, Ruben, et al.
Publicado: (2023) -
Case report: Multimodality imaging of unusual coronary to pulmonary collaterals in chronic thromboembolic pulmonary hypertension
por: Goyal, Ansh, et al.
Publicado: (2023) -
Relationship of left ventricular outflow tract velocity time integral to treatment strategy in submassive and massive pulmonary embolism
por: Antoine, David, et al.
Publicado: (2020) -
Timing of Intubation in Coronavirus Disease 2019: A Study of Ventilator Mechanics, Imaging, Findings, and Outcomes
por: Bavishi, Avni A., et al.
Publicado: (2021) -
Wnt5a is associated with right ventricular dysfunction and adverse outcome in dilated cardiomyopathy
por: Abraityte, Aurelija, et al.
Publicado: (2017)